MOLA BIOTECHNOLOGIES, LLC

MOLA BIOTECHNOLOGIES, LLC specializes in advanced biotechnological research and development services, leveraging cutting-edge molecular biology, genomic analysis, and bioinformatics platforms to support federal scientific missions. Their core capabilities center on experimental design, high-throughput data generation, and computational modeling of biological systems, with particular expertise in protein characterization, pathogen detection methodologies, and biosensor development. The firm distinguishes itself through its integrated approach to translating laboratory findings into actionable intelligence, combining wet-lab validation with machine learning-driven data interpretation to address complex biological challenges. Their technical proficiency spans next-generation sequencing, CRISPR-based editing, and biosafety level 2/3 compliant workflows, enabling precise, reproducible outcomes in controlled environments. While award history is not available, the company’s primary NAICS code of 541714 indicates a focus on research and development in the life sciences, specifically in biotechnology research services. This aligns with niche verticals such as infectious disease diagnostics, biothreat characterization, and biomedical countermeasure development, positioning MOLA BIOTECHNOLOGIES as a specialized provider for mission-critical R&D in defense and public health sectors. The company is structured as a small business owned by a service-disabled veteran, certified under the VA’s SDVOSB program, which underscores its commitment to veteran-led innovation in federal science and technology markets. Headquartered in San Antonio, TX, the firm operates with a lean, mission-focused team optimized for responsive, high-integrity contract execution. Its geographic location places it within a major hub for military medical research and biodefense collaboration, enhancing its strategic alignment with federal science agencies requiring agile, certified biotech partners.